We are pleased to share details of three new companies showcasing at BioTrinity;the first is Debiopharm,
a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative prescription drugs, second is
Avacta who will be presenting their new
Affimer® technology, an engineered alternative to antibodies and finally
Liverpool ChiroChem who
produce and supply small organic molecules for biotech/pharmaceutical R&D.
Slots are filling up, so if you are keen to showcase, get in touch with email@example.com to book your place.